Although we demonstrated a modest increase in expression of CXCR3 on CD4+ T cells in cancer septic mice (which may suggest a skewing towards a Th1 response), the biological significance of this is unclear since we found no associated differences in production of the Th1 effector IFN-γ by CD4+ T cells. The gene discussed is CXCR3; the disease is cancer.